摘要
目的探析联合检验脂蛋白(a)和胆红素诊断冠心病的临床意义。方法 2016年1月—2017年8月,选取我院150例冠心病患者为观察组、150例健康体检者为对照组,使用全自动生化分析仪进行检测,钒酸氧化法检测胆红素,免疫比浊法检测脂蛋白(a),对比两组脂蛋白(a)和胆红素水平。结果观察组脂蛋白(a)水平高于对照组,总胆红素、直接胆红素、间接胆红素水平低于对照组,对比差异有统计学意义(P<0.05)。结论冠心病患者的胆红素和脂蛋白(a)水平与健康人群相比差异有统计学意义,联合检验用于冠心病的诊断具有一定的临床意义。
Objective To explore the clinical significance of combined detection of lipoprotein（a） and bilirubin in the diagnosis of coronary heart disease. Methods From January 2016 to August 2017, 150 patients with coronary heart disease were selected as observation group and 150 healthy persons as control group in our hospital. The automatic biochemical analyzer was used for detection. Vanadate oxidation method was used to detect bilirubin. The lipoprotein（a） was detected by immunoturbidimetry and the levels of lipoprotein（a） and bilirubin were compared between the two groups. Results The level of lipoprotein（a） in the observation group was higher than that in the control group. The levels of total bilirubin, direct bilirubin, and indirect bilirubin were lower than those in the control group. There was a significant difference between the two groups（P〈0.05）. Conclusion The levels of bilirubin and lipoprotein（a） in patients with coronary heart disease are significantly different from those in healthy people. The combined test has a certain clinical significance in the diagnosis of coronary heart disease.
作者
哈斯朝鲁
HA Sichaolu(Department of Clinical Laboratory Uirst Hospital of Shanxi Medical University Taiyuan Shanxi 030001,China)
出处
《中国卫生标准管理》
2018年第12期127-129,共3页
China Health Standard Management
关键词
胆红素
脂蛋白(a)
冠心病
诊断
联合检验
临床意义
bilirubin
lipoprotein（a）
coronary heart disease
diagnosis
combined test
clinical significance
